DBV Technologies | Lucro Bruto Sobre Vendas



Gross Profit On Sales Alterar Data
Acadia Pharmaceuticals USD 243.83M 19.91M 2025-06
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Amarin USD 25.13M 1.78M 2025-03
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
DBV Technologies -30442000 30.56M 2024-09
Halozyme Therapeutics USD 279.36M 62.9M 2025-06
Incyte USD 1.14B 151.67M 2025-06
Insmed USD 78.08M 6.53M 2025-06
Ionis Pharmaceuticals USD 448M 317.85M 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
PTC Therapeutics USD 163.39M 999.84M 2025-06
Sarepta Therapeutics USD 457.87M 149.43M 2025-06
Ultragenyx Pharmaceutical USD 143.49M 32.86M 2025-06
United Therapeutics USD 711M 9.1M 2025-06


DBV Technologies Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.